What you should know:
1. Dr. Ohara will develop strategies and communication plans for the payer market and manage reimbursement around Aerie’s two drugs.
2. Mr. Jones will handle global tax-related functions at Aerie.
3. Both received stock options that will vest over a four-year period.
More articles on surgery centers:
PE-backed Prism Vision snags Maryland eye group — 4 insights
Florida ASC buyer projects $18M profit in 1st year: 5 details
Physician-owned eye group acquires California practice
